Neurobiology of Mental Illness

ILLNESS; GARY D. TOLLEFSON; PART III PSYCHOSES; SECTION EDITOR: JEFFREY LIEBERMAN; INTRODUCTION: JEFFREY LIEBERMAN; 18. DIAGNOSIS OF SCHIZOPHRENIA; MICHAEL B. FIRST; 19. GENETICS OF SCHIZOPHRENIA; XIANGNING CHEN, BRIEN RILEY AND KENNETH S. KENDLER; 20. NEUROBIOLOGICAL THEORIES OF SCHIZOPHRENIA; DAVID A. LEWIS AND DAVID W. VOLK; 21. POSTMORTEM AND NN VIVO STRUCTURAL PATHOLOGY IN SCHIZOPHRENIA; ANDREW J. DWORK, JOHN F. SMILEY, TIZIANO CALIBAZZI, MATTHEW J. HOPTMAN; 22. COGNITIVE NEUROSCIENCE AND NEUROIMAGING IN SCHIZOPHRENIA; AYSENIL BELGER AND DEANNA M. BARCH; 23. THE NEUROCHEMISTRY OF SCHIZOPHRENIA: A FOCUS ON DOPAMINE AND GLUTAMATE; ANISSA ABI-DARGHAM; 24. PRINCIPLES OF PHARMACOTHERAPY OF SCHIZOPHRENIA; CAROL A. TAMMINGA; PART IV MOOD DISORDERS; SECTION EDITOR: CHARLES B. NEMEROFF; INTRODUCTION: CHARLES B. NEMEROFF; 25. DIAGNOSTIC CLASSIFICATION OF MOOD DISORDERS: HISTORICAL CONTEXT AND IMPLICATIONS FOR NEUROBIOLOGY; S. NASSIR GHAEMI, AND FREDERICK K. GOODWIN; 26. GENETICS OF MOOD DISORDERS; FALK W. LOHOFF AND WADE H. BERRETTINI; 27. ANIMAL MODELS OF MOOD DISORDERS; INGE SILLABER, FLORIAN HOLSBOER, AND CARSTEN T. WOTJAK; 28. CELLULAR PLASTICITY CASCADES: GENES TO BEHAVIOR PATHWAYS IN THE PATHOPHYSIOLOGY AND TREATMENT OF BIPOLAR DISORDER; LISA A. CATAPANO, GUANG CHEN, JING DU, CARLOS A. ZARATE, JR., AND HUSSEINI K. MANJI; 29. NEUROCHEMICAL THEORIES OF DEPRESSION: PRECLINIAL STUDIES; RONALD S. DUMAN; 30. THE NEUROCHEMISTRY OF DEPRESSIVE DISORDERS: CLINICAL STUDIES; BOADIE DUNLOP; 31. NEUROIMAGING STUDIES OF MOOD DISORDERS; WAYNE C. DREVETS; 32. PRINCIPLES OF THE PHARMACOLOGY OF DEPRESSION; ROBERT M. BERMAN, JONATHAN SPORN, JOSEPH K. BELANOFF, DENNIS S. CHARNEY, AND ALAN SCHATZBERG; 33. ABNORMALITIES OF BRAIN STRUCTURE AND FUNCTION IN MOOD DISORDERS; VICTORIA ARANGO AND J. JOHN MANN; 34. NOVEL TARGETS FOR ANTIDEPRESSANT TREATMENTS; OLIVIER BERTON AND ERIC J. NESTLER; 35. THE NEUROBIOLOGY OF MENSTRUAL-CYCLE RELATED MOOD DISORDERS; DAVID R. RUBINOW, PETER J. SCHMIDT, SAMANTHA MELTZER-BRODY, AND VERONICA HARSH; 36. DEPRESSION AND MEDICAL ILLNESS; TAMI D. BENTON, PAUL CRITS-CHRISTOPH, BENOIT DUBE, AND DWIGHT L. EVANS; PART V ANXIETY DISORDERS; SECTION EDITOR: ANTONIA NEW; INTRODUCTION: ANTONIA NEW; 37. DIAGNOSTIC CLASSIFICATION OF ANXIETY DISORDERS: DSM-V AND BEYOND; MURRAY B. STEIN AND O. JOSEPH BIENVENU; 38. THE MOLECULAR GENETICS OF ANXIETY DISORDERS; STEVEN P. HAMILTON AND ABBY J. FYER; 39. THE NEUROBIOLOGY OF FEAR AND ANXIETY: CONTRIBUTIONS OF ANIMAL MODELS TO CURRENT UNDERSTANDING; GREGORY M. SULLIVAN, JACEK DEBIEC, DAVID E. A. BUSH, DAVID M. LYONS, AND JOSEPH E. LEDOUX; 40. STRESS-INDUCED STRUCTURAL AND FUNCTIONAL PLASTICITY IN THE BRAIN: PROTECTION, DAMAGE AND BRAIN-BODY COMMUNICATION; BRUCE S. MCEWEN; 41. THE NEUROBIOLOGY OF ANXIETY DISORDERS; AMIR GARAKANI, JAMES W. MURROUGH, DENNIS S. CHARNEY, AND DOUGLAS BREMNER; 42. THE NEUROBIOLOGY AND TREATMENT OF OBSESSIVE COMPULSIVE DISORDER; SUSAN E. SWEDO AND PAUL GRANT; 43. NEUROIMAGING STUDIES OF ANXIETY DISORDERS; JUSTINE M. KENT AND SCOTT L. RAUCH; 44. PHARMACOTHERAPY OF ANXIETY DISORDERS; SANJAY J. MATHEW, ELLEN J. HOFFMAN, AND DENNIS S. CHARNEY; 45. ANIMAL MODELS OF ADDICTION; ELIOT L. GARDNER AND ROY A. WISE; PART VI SUBSTANCE ABUSE DISORDERS; SECTION EDITOR: STEVEN E. HYMAN; INTRODUCTION: STEVEN E. HYMAN; 46. CELLULAR AND MOLECULAR MECHANISMS OF DRUG ADDICTION; ERIC J. NESTLER; 47. GENETIC EPIDEMIOLOGY OF SUBSTANCE USE DISORDERS; KATHLEEN R. MERIKANGAS AND KEVIN P. CONWAY; 48. EFFECTS OF DRUGS OF ABUSE ON BRAIN DEVELOPMENT; BARRY M. LESTER AND BARRY E. KOSOFSKY; 49. PET AND SPECT IMAGING IN SUBSTANCE ABUSE RESEARCH; JOANNA S. FOWLER AND NORA D. VOLKOW; 50. BRAIN REWARD AND FMRI; P. READ MONTAGUE AND PEARL H. CHIU; 51. PRINCIPLES OF THE PHARMACOTHERAPY OF ADDICTIVE DISORDERS; CHARLES P. O'BRIEN AND CHARLES DACKIS; PART VII DEMENTIA; SECTION EDITOR: MARY SANO; INTRODUCTION: MARY SANO; 52. THE GENETICS AND PATHOGENESIS OF ALZHEIMER'S DISEASE AND RELATED DEMENTIAS; JOHN HARDY; 53. DIAGNOSTIC CLASSIFICATIONS: RELATIONSHIP TO THE NEUROBIOLOGY OF DEMENTIA; STEVEN DANIEL I. KAUFER AND STEVEN T. DEKOSKY; 54. TRANSGENIC MODELS OF DEMENTIAS; GREGORY A. ELDER; 55. FUNCTIONAL NEUROANATOMY OF LEARNING AND MEMORY; GARY L. WENK; 56. NEUROCHEMICAL SYSTEMS INVOLVED IN LEARNING AND MEMORY; JOANNE BERGER-SWEENEY, LAURA R. SCHAEVITZ, AND KARYN FRICK; 57. NEUROPATHOLOGICAL AND NEUROIMAGING STUDIES OF THE HIPPOCAMPUS IN NORMAL AGING AND IN ALZHEIMER'S DISEASE; EFFIE M. MITSIS, MACIEK BOBINSKI, MIROSLAW BRYS, LIDIA GLODZIK-SOBANSKA, SUSAN DE SANTI, YI LI, BYEONG-CHE KIM, LISA MOSCONI, AND MONY J. DE LEON; 58. ABNORMALITIES IN BRAIN STRUCTURE ON POSTMORTEM ANALYSIS OF DEMENTIA; DANIEL P. PERL; 59. FUNCTIONAL BRAIN IMAGING STUDIES IN DEMENTIA; MONTE S. BUCHSBAUM, ADAM BRICKMAN, JING ZHANG, AND ERIN A. HAZLETT; 60. PRINCIPLES OF PHARMACOTHERAPY OF DEMENTIA; CHRISTINE BERGMANN AND MARY SANO; 61. COGNITIVE IMPAIRMENT IN DEMYELINATING DISEASE; THOMAS M. HYDE; 62. DEMENTIA WITH LEWY BODIES; DAVID J. BURN, ELAINE K. PERRY, JOHN T. O'BRIEN, NEIL ARCHIBALD, ELIZABETA B. MUKAETOVA-LADINSKA, JOAQUIM CEREJEIRA, DANIEL COLLERTON, EVELYN JAROS, ROBERT PERRY, MARGARET A. PIGGOTT, CHRIS M. MORRIS, ANDREW MCLAREN, CLIVE G. BALLARD, AND IAN G. MCKEITH; 63. DEMENTIA IN PARKINSON'S DISEASE; MARTIN GOLDSTEIN AND C. WARREN OLANOW; 64. MILD COGNITIVE IMPAIRMENT; BRENDAN J. KELLEY AND RONALD C. PETERSEN; 65. FRONTOTEMPORAL DEMENTIA; STEVEN Z. CHAO, INDRE VISKONTAS, AND BRUCE L. MILLER; 66. VASCULAR DEMENTIA; NANCY NIELSEN-BROWN AND HELENA C. CHUI; PART VIII PSYCHIATRIC DISORDERS OF CHILDHOOD ONSET; SECTION EDITOR: DANIEL PINE; INTRODUCTION: DANIEL PINE; 67. THE NEUROBIOLOGY OF INTELLECTUAL DISABILITIES; ANTONIO Y. HARDAN AND ALLAN L. REISS; 68. COGNITIVE NEUROSCIENCE APPROACHES TO TYPICAL AND ATYPICAL DEVELOPMENT; B.J. CASEY AND SARAH DURSTON; 69. THE NEUROBIOLOGY OF IMPULSIVITY AND SELF-REGULATORY CONTROL IN CHILDREN WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; KERSTIN J. PLESSEN AND BRADLEY S. PETERSON; 70. CHILDHOOD ANXIETY DISORDERS: A COGNITIVE NEUROBIOLOGICAL PERSPECTIVE; CHRISTOPHER S. MONK AND DANIEL S. PINE; 71. MOLECULAR GENETICS OF CHILDHOOD AND ADOLESCENT ONSET PSYCHIATRIC DISORDERS; JEREMY VEENSTRA-VANDERWEELE, RANDY D. BLAKELY, AND EDWIN H. COOK, JR; 72. PEDIATRIC BIPOLAR DISORDER; ELLEN LEIBENLUFT; 73. NEUROBIOLOGY OF CHILD AND ADOLESCENT DEPRESSION; JOAN KAUFMAN, ANDRES MARTIN, AND HILARY BLUMBERG; 74. STRUCTURAL MAGNETIC RESONANCE IMAGING OF TYPICAL PEDIATRIC BRAIN DEVELOPMENT; JAY N. GIEDD, SAMANTHA WHITE, AND MARK CELANO; 75. TOURETTE'S SYNDROME AND TIC REALTED DISORDERS IN CHILDREN; PAUL J. LOMBROSO, MICHAEL H. BLOCK, AND JAMES F. LECKMAN; 76. THE NEUROBIOLOGY OF CHILDHOOD PSYCHOTIC DISORDERS; NITIN GOGTAY AND JUDITH RAPOPORT; 77. DEVELOPMENTAL PERSPECTIVES ON PSYCHOPATHOLOGY; MIKE RUTTER; 78. NEUROBIOLOGY OF AUTISM AND THE PERVASIVE DEVELOPMENTAL DISORDERS; SARAH SPENCE, PAUL GRANT, AUDREY THURM, AND SUSAN SWEDO; PART IX SPECIAL TOPIC AREAS; SECTION EDITOR: ANTONIA NEW; 79. NEUROPSYCHIATRY: THE BORDER BETWEEN NEUROLOGY AND PSYCHIATRY; WILLIAM M. MCDONALD AND MICHAEL S. OKUN; 80. THE NEUROBIOLOGY OF PERSONALITY DISORDERS; ANTONIA S. NEW, JOSEPH TRIEBWASSER AND MARIANNE GOODMAN; 81. THE NEUROBIOLOGY OF AGGRESSION; R. J. R. BLAIR; 82. SEXUAL DYSFUNCTION AND PHARMACOLOGICAL TREATMENT: BIOLOGICAL INTERACTIONS; STUART N. SEIDMAN, STEVEN P. ROOSE, RAYMOND C. ROSEN; 83. THE NEUROBIOLOGY OF SOCIAL ATTACHMENT; THOMAS R. INSEL AND JAMES T. WINSLOW; 84. THE NEUROBIOLOGY OF EATING DISORDERS; WALTER KAYE, MICHAEL STROBER, AND DAVID JIMERSON; 85. THE NEUROBIOLOGY OF SLEEP; GIULIO TONONI AND CHIARA CIRELLI; 86. THE NEUROBIOLOGY OF RESILIENCE; MARGARET HAGLUND, PAUL NESTADT, NICOLE S. COOPER, STEVEN SOUTHWICK, AND DENNIS S. CHARNEY; 87. A BRIEF HISTORY OF NEURAL EVOLUTION; DANIEL R. WILSON